While proteasome inhibition alters the degradation of many proteins, it was highlighted that proteasome inhibition benefits cancer patients by repressing NF-κB signaling, which correlates with cancer proliferation, metastasis, and avoidance of apoptosis79. The gene discussed is NFKB1; the disease is cancer.